A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00810953
Recruitment Status : Completed
First Posted : December 18, 2008
Last Update Posted : June 28, 2011
Information provided by:
Oncozyme Pharma Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2010
  Actual Study Completion Date : June 2011